ZA200105009B - Skin care compositions containing cis-9, trans-11 linoleic acid. - Google Patents

Skin care compositions containing cis-9, trans-11 linoleic acid. Download PDF

Info

Publication number: ZA200105009B
Authority: ZA; South Africa
Prior art keywords: skin; cla; linoleic acid; conjugated linoleic; isomer
Prior art date: 1998-12-22

Application number

ZA200105009A

Other languages

English (en)

Inventor

Simon Alaluf

Martin Richard Green

Clive Roderick Harding

Heng-Long Hu

Gerald Patrick Mcneill

Jonathan Richard Powell

Anthony Vincent Rawlings

Julie Sarah Rogers

Allan Watkinson

Original Assignee

Unilever Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-22

Filing date

2001-06-19

Publication date

2002-06-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10844842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200105009(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-06-19 Application filed by Unilever Plc filed Critical Unilever Plc

2002-06-19 Publication of ZA200105009B publication Critical patent/ZA200105009B/en

Links

239000000203 mixture Substances 0.000 title claims description 71
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 title claims description 20
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 title description 4
235000020778 linoleic acid Nutrition 0.000 title description 4
238000000034 method Methods 0.000 claims description 27
JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 21
239000002537 cosmetic Substances 0.000 claims description 18
206010051246 Photodermatosis Diseases 0.000 claims description 16
229940108924 conjugated linoleic acid Drugs 0.000 claims description 16
230000000699 topical effect Effects 0.000 claims description 16
208000003251 Pruritus Diseases 0.000 claims description 9
238000007665 sagging Methods 0.000 claims description 8
206010013786 Dry skin Diseases 0.000 claims description 6
230000037336 dry skin Effects 0.000 claims description 6
230000037307 sensitive skin Effects 0.000 claims description 6
JBYXPOFIGCOSSB-UQGDGPGGSA-N rumenic acid Chemical compound CCCCCC\C=C/C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-UQGDGPGGSA-N 0.000 claims description 4
210000003491 skin Anatomy 0.000 description 81
102000004237 Decorin Human genes 0.000 description 23
108090000738 Decorin Proteins 0.000 description 23
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 17
230000002500 effect on skin Effects 0.000 description 16
239000000047 product Substances 0.000 description 16
210000002510 keratinocyte Anatomy 0.000 description 15
238000012360 testing method Methods 0.000 description 15
210000004027 cell Anatomy 0.000 description 14
235000014113 dietary fatty acids Nutrition 0.000 description 14
239000000194 fatty acid Substances 0.000 description 14
229930195729 fatty acid Natural products 0.000 description 14
210000002950 fibroblast Anatomy 0.000 description 14
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 13
230000015572 biosynthetic process Effects 0.000 description 13
230000000694 effects Effects 0.000 description 13
229930002330 retinoic acid Natural products 0.000 description 13
229960001727 tretinoin Drugs 0.000 description 13
239000003981 vehicle Substances 0.000 description 13
150000001875 compounds Chemical class 0.000 description 12
150000004665 fatty acids Chemical class 0.000 description 12
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
235000019333 sodium laurylsulphate Nutrition 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
239000003795 chemical substances by application Substances 0.000 description 10
239000003921 oil Substances 0.000 description 10
239000003656 tris buffered saline Substances 0.000 description 10
108010035532 Collagen Proteins 0.000 description 9
102000008186 Collagen Human genes 0.000 description 9
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
239000002253 acid Substances 0.000 description 9
230000008901 benefit Effects 0.000 description 9
229920001436 collagen Polymers 0.000 description 9
230000004069 differentiation Effects 0.000 description 9
238000010790 dilution Methods 0.000 description 9
239000012895 dilution Substances 0.000 description 9
LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 9
239000012528 membrane Substances 0.000 description 9
235000019198 oils Nutrition 0.000 description 9
238000003786 synthesis reaction Methods 0.000 description 9
230000003712 anti-aging effect Effects 0.000 description 8
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 7
210000000245 forearm Anatomy 0.000 description 7
230000001965 increasing effect Effects 0.000 description 7
230000008439 repair process Effects 0.000 description 7
210000002966 serum Anatomy 0.000 description 7
230000037303 wrinkles Effects 0.000 description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
-1 phosphoesters) Chemical class 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
150000003626 triacylglycerols Chemical class 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
108010050808 Procollagen Proteins 0.000 description 5
241000030538 Thecla Species 0.000 description 5
150000007513 acids Chemical class 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
239000003636 conditioned culture medium Substances 0.000 description 5
150000002148 esters Chemical class 0.000 description 5
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
239000000463 material Substances 0.000 description 5
239000002609 medium Substances 0.000 description 5
230000008845 photoaging Effects 0.000 description 5
108091003079 Bovine Serum Albumin Proteins 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
102000004142 Trypsin Human genes 0.000 description 4
108090000631 Trypsin Proteins 0.000 description 4
230000032683 aging Effects 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
238000003556 assay Methods 0.000 description 4
229940098773 bovine serum albumin Drugs 0.000 description 4
230000008021 deposition Effects 0.000 description 4
229940068196 placebo Drugs 0.000 description 4
239000000902 placebo Substances 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
239000000243 solution Substances 0.000 description 4
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
239000012588 trypsin Substances 0.000 description 4
230000003827 upregulation Effects 0.000 description 4
230000035899 viability Effects 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
239000004367 Lipase Substances 0.000 description 3
102000004882 Lipase Human genes 0.000 description 3
108090001060 Lipase Proteins 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
229920001213 Polysorbate 20 Polymers 0.000 description 3
108010090804 Streptavidin Proteins 0.000 description 3
108060008539 Transglutaminase Proteins 0.000 description 3
238000010306 acid treatment Methods 0.000 description 3
239000003513 alkali Substances 0.000 description 3
239000000427 antigen Substances 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
230000003833 cell viability Effects 0.000 description 3
230000000052 comparative effect Effects 0.000 description 3
238000004821 distillation Methods 0.000 description 3
210000002744 extracellular matrix Anatomy 0.000 description 3
235000021588 free fatty acids Nutrition 0.000 description 3
235000011187 glycerol Nutrition 0.000 description 3
230000003810 hyperpigmentation Effects 0.000 description 3
208000000069 hyperpigmentation Diseases 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
239000002085 irritant Substances 0.000 description 3
235000019421 lipase Nutrition 0.000 description 3
150000002632 lipids Chemical group 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
238000000926 separation method Methods 0.000 description 3
210000000434 stratum corneum Anatomy 0.000 description 3
231100000419 toxicity Toxicity 0.000 description 3
230000001988 toxicity Effects 0.000 description 3
102000003601 transglutaminase Human genes 0.000 description 3
LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
241000235395 Mucor Species 0.000 description 2
229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
102000016611 Proteoglycans Human genes 0.000 description 2
108010067787 Proteoglycans Proteins 0.000 description 2
241000235403 Rhizomucor miehei Species 0.000 description 2
235000019485 Safflower oil Nutrition 0.000 description 2
206010000496 acne Diseases 0.000 description 2
150000003863 ammonium salts Chemical class 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
230000008436 biogenesis Effects 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
239000000872 buffer Substances 0.000 description 2
229960000541 cetyl alcohol Drugs 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000006071 cream Substances 0.000 description 2
230000002542 deteriorative effect Effects 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
210000003953 foreskin Anatomy 0.000 description 2
238000009472 formulation Methods 0.000 description 2
239000000499 gel Substances 0.000 description 2
230000005484 gravity Effects 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
125000004356 hydroxy functional group Chemical group O* 0.000 description 2
230000006872 improvement Effects 0.000 description 2
239000006210 lotion Substances 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
238000000199 molecular distillation Methods 0.000 description 2
238000000329 molecular dynamics simulation Methods 0.000 description 2
PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 2
239000012071 phase Substances 0.000 description 2
230000008832 photodamage Effects 0.000 description 2
230000002265 prevention Effects 0.000 description 2
230000008569 process Effects 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
230000004044 response Effects 0.000 description 2
235000005713 safflower oil Nutrition 0.000 description 2
239000003813 safflower oil Substances 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000002904 solvent Substances 0.000 description 2
239000011550 stock solution Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical class OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
MGYUQZIGNZFZJS-KTKRTIGZSA-N 2-[2-[(z)-octadec-9-enoxy]ethoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCOCCO MGYUQZIGNZFZJS-KTKRTIGZSA-N 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
244000020518 Carthamus tinctorius Species 0.000 description 1
235000003255 Carthamus tinctorius Nutrition 0.000 description 1
229920000298 Cellophane Polymers 0.000 description 1
101100006825 Cochliobolus lunatus clz2 gene Proteins 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
241000283074 Equus asinus Species 0.000 description 1
241000159512 Geotrichum Species 0.000 description 1
244000168141 Geotrichum candidum Species 0.000 description 1
235000017388 Geotrichum candidum Nutrition 0.000 description 1
101001000206 Homo sapiens Decorin Proteins 0.000 description 1
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical class CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
206010040880 Skin irritation Diseases 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
238000004378 air conditioning Methods 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
150000001447 alkali salts Chemical class 0.000 description 1
229910052784 alkaline earth metal Chemical class 0.000 description 1
WLDHEUZGFKACJH-UHFFFAOYSA-K amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1N=NC1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-UHFFFAOYSA-K 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000002585 base Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
244000309466 calf Species 0.000 description 1
230000001914 calming effect Effects 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
229940106189 ceramide Drugs 0.000 description 1
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
229940096422 collagen type i Drugs 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000013256 coordination polymer Substances 0.000 description 1
210000000736 corneocyte Anatomy 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
239000007854 depigmenting agent Substances 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
239000013024 dilution buffer Substances 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
235000004626 essential fatty acids Nutrition 0.000 description 1
239000010696 ester oil Substances 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
150000002190 fatty acyls Chemical group 0.000 description 1
238000001914 filtration Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000012634 fragment Substances 0.000 description 1
210000002816 gill Anatomy 0.000 description 1
238000009499 grossing Methods 0.000 description 1
102000045840 human DCN Human genes 0.000 description 1
239000003906 humectant Substances 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
239000008309 hydrophilic cream Substances 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
238000002991 immunohistochemical analysis Methods 0.000 description 1
231100000021 irritant Toxicity 0.000 description 1
238000002955 isolation Methods 0.000 description 1
230000000366 juvenile effect Effects 0.000 description 1
239000003550 marker Substances 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
230000037311 normal skin Effects 0.000 description 1
239000003605 opacifier Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000002304 perfume Substances 0.000 description 1
238000011020 pilot scale process Methods 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
239000003380 propellant Substances 0.000 description 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
238000007388 punch biopsy Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
238000007127 saponification reaction Methods 0.000 description 1
230000001953 sensory effect Effects 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
229910000077 silane Inorganic materials 0.000 description 1
229920002545 silicone oil Polymers 0.000 description 1
230000037075 skin appearance Effects 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
230000036556 skin irritation Effects 0.000 description 1
231100000475 skin irritation Toxicity 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
230000000475 sunscreen effect Effects 0.000 description 1
239000000516 sunscreening agent Substances 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
231100000747 viability assay Toxicity 0.000 description 1
238000003026 viability measurement method Methods 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
239000007762 w/o emulsion Substances 0.000 description 1
239000008096 xylene Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Birds (AREA)
Epidemiology (AREA)
Gerontology & Geriatric Medicine (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)

ZA200105009A 1998-12-22 2001-06-19 Skin care compositions containing cis-9, trans-11 linoleic acid. ZA200105009B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9828379.9A GB9828379D0 (en)	1998-12-22	1998-12-22	Skin care composition

Publications (1)

Publication Number	Publication Date
ZA200105009B true ZA200105009B (en)	2002-06-19

Family

ID=10844842

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200105009A ZA200105009B (en)	1998-12-22	2001-06-19	Skin care compositions containing cis-9, trans-11 linoleic acid.

Country Status (19)

Country	Link
US (1)	US6287553B1 (zh)
EP (1)	EP1140003B2 (zh)
JP (1)	JP4460169B2 (zh)
CN (1)	CN1217651C (zh)
AR (1)	AR021949A1 (zh)
AT (1)	ATE482749T1 (zh)
AU (1)	AU767130B2 (zh)
BR (1)	BR9916450B1 (zh)
CA (1)	CA2355633C (zh)
CZ (1)	CZ302773B6 (zh)
DE (1)	DE69942807D1 (zh)
ES (1)	ES2350900T5 (zh)
GB (1)	GB9828379D0 (zh)
MX (1)	MXPA01006455A (zh)
PL (1)	PL200949B1 (zh)
RU (1)	RU2253443C2 (zh)
TW (1)	TWI250025B (zh)
WO (1)	WO2000037040A1 (zh)
ZA (1)	ZA200105009B (zh)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6136985A (en) *	1997-12-23	2000-10-24	Dcv, Inc.	CLA esters and uses thereof
US6132582A (en)	1998-09-14	2000-10-17	The Perkin-Elmer Corporation	Sample handling system for a multi-channel capillary electrophoresis device
US6296861B1 (en) *	1999-05-03	2001-10-02	Nicholas V. Perricone	Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters
AU6402700A (en) *	1999-07-09	2001-01-30	Monsanto Company	Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
GB9918028D0 (en) *	1999-07-30	1999-09-29	Unilever Plc	Skin care composition
ITMI991894A1 (it)	1999-09-09	2001-03-09	Carlo Ghisalberti	Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
NO20005718A (no)	2000-11-13	2001-06-05	Ethics Cosmeceuticals Ab	Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugert vitamin A samt fremgangsmåte for fremstilling og anvendelse av denne
US6908946B2 (en) *	2001-05-31	2005-06-21	Wisconsin Alumni Research Foundation	Conjugated nonadecadienoic acid compositions
US20030059450A1 (en)	2001-09-24	2003-03-27	Maibach Howard I.	Method and topical formulation for treating skin conditions associated with aging
US6677470B2 (en) *	2001-11-20	2004-01-13	Natural Asa	Functional acylglycerides
TW200407172A (en)	2002-10-17	2004-05-16	Unilever Nv	Scalp treatment
US7074418B2 (en) *	2002-11-18	2006-07-11	Changaris David G	Conjugated fatty acid based emulsion and methods for preparing and using same
MXPA05013857A (es) *	2003-06-25	2006-05-17	Charles Erwin	Combinacion quimica y metodo para aumentar la liberacion de coenzima q10.
US7193096B2 (en) *	2003-07-01	2007-03-20	Loders Croklaan Usa Llc	Process for producing a conjugated di- or poly-unsaturated fatty acid of 12 to 24 carbon atoms or salt or ester thereof
JP2005247826A (ja) *	2004-02-04	2005-09-15	Kose Corp	デコリン産生促進剤及びそれを含有する皮膚外用剤
US20050186231A1 (en) *	2004-02-19	2005-08-25	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Stabilization with substituted ureas against color degradation of personal care products
AU2005291098B2 (en) *	2004-10-04	2011-11-24	L'oreal	Cosmetic and/or dermatological composition for sensitive skins
FR2889057B1 (fr) *	2005-08-01	2008-07-18	Oreal	Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
NZ543486A (en) *	2005-11-10	2009-03-31	Fonterra Corporate Res And Dev	Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof
US7175836B1 (en)	2005-12-23	2007-02-13	Conopco, Inc.	Oil continuous phase cosmetic emulsions with conjugated linoleic acid
US7175835B1 (en)	2005-12-23	2007-02-13	Conopco, Inc.	Cosmetic emulsions with inorganic sunscreens stabilized with conjugated linoleic acid
US7172754B1 (en)	2005-12-23	2007-02-06	Conopco, Inc.	Cosmetic emulsions with sunscreens and conjugated linoleic acid
US20070189989A1 (en) *	2006-02-16	2007-08-16	Cantwell Maggie Y	Cosmetic compositions and methods of making and using the compositions
ES2283212B1 (es)	2006-03-31	2008-08-16	Lipotec S.A.	Peptidos sinteticos utiles en el tratamiento de la piel y su uso en composiciones cosmeticas o dermofarmaceuticas.
WO2007118614A1 (en) *	2006-04-13	2007-10-25	Lipid Nutrition B.V.	Process for producing isomer enriched conjugated linoleic acid compositions
WO2008043856A1 (en) *	2006-10-13	2008-04-17	Compagnie Gervais Danone	New composition for improving skin quality and a process for preparing the same
EP1923066A1 (de) *	2006-11-08	2008-05-21	Cognis IP Management GmbH	Eine Zusammensetzung enthaltend Rotbuschtee und konjugierte Linolsäure
FI20075417A0 (fi) *	2007-06-05	2007-06-05	Marjo-Riitta Suuronen	Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
HU227970B1 (en)	2007-07-10	2012-07-30	Egis Gyogyszergyar Nyrt	Pharmaceutical compositions containing silicones of high volatility
FR2919501B1 (fr) *	2007-08-02	2010-12-31	Oreal	Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920305B1 (fr) *	2007-09-04	2010-07-30	Oreal	Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) *	2007-09-04	2010-06-25	Oreal	Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
MX2010002247A (es) *	2007-09-04	2010-05-17	Oreal	Uso de una combinacion de hesperidina y de un microorganismo para influir en la funcion de barrera de la piel.
FR2942719B1 (fr) *	2009-03-04	2011-08-19	Oreal	Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
US10045935B2 (en)	2012-07-31	2018-08-14	Egis Pharmaceuticals Plc	Transdermal formulation containing COX inhibitors
US11154535B2 (en)	2012-07-31	2021-10-26	Egis Pharmaceuticals Plc	Transdermal formulation containing COX inhibitors
EP2982370A4 (en) *	2013-04-04	2016-10-12	Nishizaki Bioinformation Res Inst	Elastin synthesis/regeneration promoting agent
WO2016000863A1 (en)	2014-06-30	2016-01-07	Unilever Plc	Nitrogen containing borane stabilized skin care compositions
JP6113133B2 (ja) *	2014-11-06	2017-04-12	日本メナード化粧品株式会社	幹細胞の未分化状態維持剤及び増殖促進剤
WO2018019463A1 (en) *	2016-07-27	2018-02-01	Unilever Plc	Personal care compositions comprising fatty acid amide derivatives
CN114288281A (zh) *	2021-12-07	2022-04-08	上海中医药大学附属岳阳中西医结合医院	三亚油酸甘油酯在制备预防和/或治疗特应性皮炎的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB548382A (en) †	1940-12-16	1942-10-08	John Edward Mccormick	Improvements in or relating to toilet creams having cleansing properties
US3959491A (en) †	1974-10-29	1976-05-25	Stiefel Laboratories, Inc.	Stable human skin cosmetic composition containing milk
GB1545206A (en) †	1975-05-27	1979-05-02	Roney Prod & Dev Ltd	Milk-containing cosmetic compositions
US4285973A (en) *	1979-07-20	1981-08-25	Alberto-Culver Company	Liquid composition for application to the skin
FR2474310A1 (fr) *	1980-01-25	1981-07-31	Oreal	Solution stable a l'oxydation de vitamine f et d'huile de jojoba et compositions cosmetiques la contenant
FR2588187B1 (fr) *	1985-10-07	1989-04-14	Rochas Parfums	Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
DE19537297A1 (de) †	1995-07-07	1997-01-09	Paerson & Co Gmbh & Co	Kosmetische Präparate mit Wachstumsfaktoren hergestellt aus Milch und Kolostrum von Kühen und Stuten
ATE194387T1 (de) *	1995-11-14	2000-07-15	Loders Croklaan Bv	Prozess für die präparation von substanzen mit hohem gehalt an isomeren von konjugierte linölsäure
GB9621630D0 (en) *	1996-10-17	1996-12-11	Kappa Pharmaceuticals Ltd	Treatment of skin disorders
US6019990A (en) *	1997-11-21	2000-02-01	Natural Nutrition Ltd. As	Conjugated linoleic acid delivery system in cosmetic preparations

1998
- 1998-12-22 GB GBGB9828379.9A patent/GB9828379D0/en not_active Ceased
1999
- 1999-12-03 PL PL349446A patent/PL200949B1/pl not_active IP Right Cessation
- 1999-12-03 JP JP2000589151A patent/JP4460169B2/ja not_active Expired - Lifetime
- 1999-12-03 DE DE69942807T patent/DE69942807D1/de not_active Expired - Lifetime
- 1999-12-03 AT AT99963409T patent/ATE482749T1/de not_active IP Right Cessation
- 1999-12-03 EP EP99963409.0A patent/EP1140003B2/en not_active Expired - Lifetime
- 1999-12-03 RU RU2001120374/15A patent/RU2253443C2/ru active
- 1999-12-03 MX MXPA01006455A patent/MXPA01006455A/es active IP Right Grant
- 1999-12-03 WO PCT/EP1999/009589 patent/WO2000037040A1/en not_active Ceased
- 1999-12-03 CZ CZ20012333A patent/CZ302773B6/cs not_active IP Right Cessation
- 1999-12-03 CN CN998162698A patent/CN1217651C/zh not_active Expired - Lifetime
- 1999-12-03 BR BRPI9916450-7A patent/BR9916450B1/pt not_active IP Right Cessation
- 1999-12-03 AU AU19720/00A patent/AU767130B2/en not_active Ceased
- 1999-12-03 CA CA002355633A patent/CA2355633C/en not_active Expired - Lifetime
- 1999-12-03 ES ES99963409.0T patent/ES2350900T5/es not_active Expired - Lifetime
- 1999-12-13 US US09/459,698 patent/US6287553B1/en not_active Expired - Lifetime
- 1999-12-21 AR ARP990106612A patent/AR021949A1/es active IP Right Grant
2000
- 2000-03-06 TW TW089103959A patent/TWI250025B/zh not_active IP Right Cessation
2001
- 2001-06-19 ZA ZA200105009A patent/ZA200105009B/en unknown

Also Published As

Publication number	Publication date
BR9916450B1 (pt)	2013-06-04
MXPA01006455A (es)	2003-06-06
AU767130B2 (en)	2003-10-30
JP4460169B2 (ja)	2010-05-12
WO2000037040A1 (en)	2000-06-29
DE69942807D1 (de)	2010-11-11
CZ302773B6 (cs)	2011-11-02
US6287553B1 (en)	2001-09-11
AR021949A1 (es)	2002-09-04
TWI250025B (en)	2006-03-01
CN1335763A (zh)	2002-02-13
CA2355633C (en)	2009-02-10
CA2355633A1 (en)	2000-06-29
ES2350900T3 (es)	2011-01-28
RU2253443C2 (ru)	2005-06-10
CN1217651C (zh)	2005-09-07
PL200949B1 (pl)	2009-02-27
BR9916450A (pt)	2001-09-04
EP1140003B2 (en)	2014-11-19
EP1140003A1 (en)	2001-10-10
GB9828379D0 (en)	1999-02-17
EP1140003B1 (en)	2010-09-29
PL349446A1 (en)	2002-07-29
ES2350900T5 (es)	2015-01-15
JP2002532531A (ja)	2002-10-02
ATE482749T1 (de)	2010-10-15
CZ20012333A3 (cs)	2002-01-16
AU1972000A (en)	2000-07-12

Publication	Publication Date	Title
US6287553B1 (en)	2001-09-11	Skin care composition
EP1200059B1 (en)	2003-10-01	Skin care composition
EP1061896B1 (en)	2003-10-22	Cosmetic method of treating skin
ZA200200552B (en)	2003-03-26	Skin care composition.
JP4896326B2 (ja)	2012-03-14	ペトロセリン酸を含有する皮膚保護組成物
US6042841A (en)	2000-03-28	Cosmetic method of treating skin
AU2002220694B2 (en)	2005-02-10	Cosmetic method of treating skin